» Articles » PMID: 11408058

Novel Cell Lines Established from a Human Myxoid Malignant Fibrous Histiocytoma Arising in the Uterus

Overview
Date 2001 Jun 16
PMID 11408058
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Two cell lines (Nara-H and Nara-F) with different phenotypes were established from a myxoid MFH of the uterus. In vitro, Nara-F grew in sheets showing a storiform arrangement and Nara-H in raised colonies. Although tumors generated in nude mice shared similar morphological features of abundant myxoid tumor in Nara-H and -F, the pleomorphic component was conspicuous in Nara-F. Both cell lines produced hyaluronic-acid but CD44 was expressed only in Nara-H. Estrogen receptor alpha (ER alpha) and progesterone receptor (PgR) were detected in Nara-H. Nara-F was positive for ER beta and PgR. Among hormonal agents, the response to the anti-estrogen tamoxifen was more sensitive than progesterone agents. This report illustrates the characteristics of these newly established cell lines, and presents the possibility of an adjuvant hormonal therapy for MFH.

Citing Articles

Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS.

Nakahashi N, Emori M, Takada K, Murahashi Y, Shimizu J, Murase K Hum Cell. 2024; 38(1):25.

PMID: 39625530 DOI: 10.1007/s13577-024-01157-9.


Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?.

Lucarelli E, De Vita A, Bellotti C, Frisoni T, Vanni S, Guerrieri A Cancers (Basel). 2023; 15(21).

PMID: 37958307 PMC: 10650645. DOI: 10.3390/cancers15215132.


Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.

Vanni S, De Vita A, Gurrieri L, Fausti V, Miserocchi G, Spadazzi C Ther Adv Med Oncol. 2022; 14:17588359221093973.

PMID: 35782752 PMC: 9244941. DOI: 10.1177/17588359221093973.


Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.

Minoda M, Kawamoto T, Ueha T, Kamata E, Morishita M, Harada R Int J Oncol. 2015; 47(3):891-9.

PMID: 26166250 PMC: 4532197. DOI: 10.3892/ijo.2015.3077.


The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells.

Nakamura O, Hitora T, Yamagami Y, Mori M, Nishimura H, Horie R Int J Mol Med. 2014; 33(6):1491-7.

PMID: 24676456 PMC: 4055350. DOI: 10.3892/ijmm.2014.1715.